Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects

Novo Nordisk · Phase 3 · Completed · Enrollment 408

NCT06738979

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
TQF3510n/rn/rn/rn/r
Wegovy®n/rn/rn/rn/r

Not shown

  • TQF3510: endpoint not reported
  • Wegovy®: endpoint not reported